Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-13

Clinical Trial Update: IV Dexmedetomidine in the Duration of Spinal Anesthesia With Hyperbaric Bupivacaine: Double Blind Randomized Trial. [Phase 3]

View source ↗

Summary

A phase 3 randomized, double-blind trial evaluating intravenous dexmedetomidine for duration of spinal anesthesia with hyperbaric bupivacaine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Hospital Central "Dr. Ignacio Morones Prieto" | Conditions: Anesthesia, Dexmedetomidine | Phase 3 | Status: UNKNOWN